Catabasis Pharmaceuticals, Inc. (Nasdaq: CATB) To Ring The Nasdaq Stock Market Closing Bell

ADVISORY, Nov. 16, 2016 (GLOBE NEWSWIRE) --

What:Catabasis Pharmaceuticals, Inc. (Nasdaq:CATB), a clinical-stage biopharmaceutical company, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Jill C. Milne, Co-Founder and CEO, will ring the Closing Bell. 

Where:Nasdaq MarketSite - 4 Times Square - 43 rd & Broadway - Broadcast Studio

When:Thursday, November 17, 2016 - 3:45 p.m. to 4:00 p.m. ET         

Catabasis Contact:Andrea Matthews(617) 349-1971 amatthews@catabasis.com

Nasdaq MarketSite:Emily Pan(646) 441-5120 emily.pan@nasdaq.com

Feed Information:Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/

Webcast: A live stream of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.

About CatabasisAt Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART linker platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates. For more information on the Company's drug discovery platform and pipeline of drug candidates, please visit www.catabasis.com.

About NasdaqNasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of $10 trillion and approximately 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com  

-NDAQA-

Primary Logo

If you liked this article you might like

Watch: Meet This New ETF Tracking Blockchain Related Companies Like IBM

Watch: Meet This New ETF Tracking Blockchain Related Companies Like IBM

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Nasdaq, Singapore's SGX Announce Agreement Allowing Collaborative Listings

Nasdaq, Singapore's SGX Announce Agreement Allowing Collaborative Listings

Walt Disney, Tiffany, NASDAQ, Mazor Robotics: 'Mad Money' Lightning Round

Walt Disney, Tiffany, NASDAQ, Mazor Robotics: 'Mad Money' Lightning Round

A Ferocious Rotation: Cramer's 'Mad Money' Recap (Friday 6/9/17)

A Ferocious Rotation: Cramer's 'Mad Money' Recap (Friday 6/9/17)